Taiyen Biotech Co., Ltd. (TPE:1737)
Taiwan · Delayed Price · Currency is TWD 31.40
-0.05 (-0.16%)
Feb 11, 2026, 1:30 PM CST
Taiyen Biotech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 333.44 | 371.52 | 300.39 | 426.7 | 393.23 | 365.09 |
Depreciation & Amortization | 240.21 | 217.88 | 197.29 | 194.18 | 188.81 | 185.04 |
Other Amortization | 0.59 | 0.72 | 0.77 | 0.77 | 0.85 | 0.97 |
Loss (Gain) From Sale of Assets | 1.05 | 1.04 | 1.28 | 1.28 | 1.24 | 1.76 |
Loss (Gain) From Sale of Investments | -5.01 | -12.85 | -7.43 | 0.36 | 0.54 | -3.17 |
Loss (Gain) on Equity Investments | - | - | - | - | - | 0.55 |
Provision & Write-off of Bad Debts | 20.87 | 84.28 | 73.56 | - | - | - |
Other Operating Activities | -18.45 | -99.33 | -82.47 | -38.21 | 24.4 | 0.73 |
Change in Accounts Receivable | 33.19 | 79.84 | -85.84 | 104.75 | -215.15 | -190.37 |
Change in Inventory | -97.75 | -80.03 | -2.9 | -25.23 | -97.12 | -8.54 |
Change in Accounts Payable | -17.87 | 25.68 | 21.35 | -104.6 | 187.74 | 93.86 |
Change in Unearned Revenue | 37.74 | 11.73 | -4.2 | 23.21 | 45.84 | 10.93 |
Change in Other Net Operating Assets | 19.08 | 59.64 | 42.74 | -2.52 | 69.71 | -117.49 |
Operating Cash Flow | 547.1 | 660.12 | 454.54 | 580.69 | 600.08 | 339.36 |
Operating Cash Flow Growth | 3.07% | 45.23% | -21.72% | -3.23% | 76.83% | 3.26% |
Capital Expenditures | -269.27 | -307.61 | -341.65 | -246.11 | -388.79 | -264.77 |
Sale of Property, Plant & Equipment | 0.1 | 0.01 | - | 0.14 | 0.27 | 0.03 |
Sale (Purchase) of Intangibles | 4.48 | - | -3.48 | -0.49 | -2.02 | -3.12 |
Sale (Purchase) of Real Estate | - | - | - | - | -1 | 1.3 |
Investment in Securities | 33 | 14.07 | -29.29 | 1.27 | 28.79 | -1.17 |
Other Investing Activities | 82.66 | 5.77 | 35.12 | 15.56 | 11.37 | 15.29 |
Investing Cash Flow | -149.03 | -287.76 | -339.3 | -229.64 | -351.38 | -252.45 |
Short-Term Debt Issued | - | 350 | 290 | 440 | 615.6 | 40.2 |
Long-Term Debt Issued | - | - | 20 | 25.26 | - | - |
Total Debt Issued | 234 | 350 | 310 | 465.26 | 615.6 | 40.2 |
Short-Term Debt Repaid | - | -352 | -210 | -707.53 | -358.07 | -50 |
Long-Term Debt Repaid | - | -25.65 | -19.83 | -15.68 | -19.95 | -17.28 |
Total Debt Repaid | -341.55 | -377.65 | -229.83 | -723.21 | -378.02 | -67.28 |
Net Debt Issued (Repaid) | -107.55 | -27.65 | 80.17 | -257.95 | 237.58 | -27.08 |
Common Dividends Paid | -260 | -240 | -300 | -300 | -270 | -300 |
Other Financing Activities | -20.47 | 1.12 | 20.61 | 9.97 | 3.98 | 146.41 |
Financing Cash Flow | -388.02 | -266.53 | -199.22 | -547.98 | -28.44 | -180.68 |
Foreign Exchange Rate Adjustments | -1.42 | 0.75 | -0.39 | 0.24 | -0.12 | 0.3 |
Net Cash Flow | 8.62 | 106.58 | -84.36 | -196.68 | 220.14 | -93.46 |
Free Cash Flow | 277.82 | 352.51 | 112.89 | 334.58 | 211.29 | 74.59 |
Free Cash Flow Growth | 18.18% | 212.26% | -66.26% | 58.35% | 183.28% | 62.19% |
Free Cash Flow Margin | 8.49% | 10.89% | 3.31% | 9.26% | 5.16% | 2.38% |
Free Cash Flow Per Share | 1.39 | 1.76 | 0.56 | 1.67 | 1.05 | 0.37 |
Cash Interest Paid | 5.81 | 6.3 | 3.3 | 4.68 | 5.73 | 3.6 |
Cash Income Tax Paid | 95.53 | 125.37 | 89.85 | 133.44 | 89.14 | 84.31 |
Levered Free Cash Flow | 270.2 | 293.46 | 167.07 | 211.65 | 180.73 | -49.24 |
Unlevered Free Cash Flow | 273.77 | 297.42 | 169.16 | 214.48 | 184.44 | -46.99 |
Change in Working Capital | -25.61 | 96.86 | -28.84 | -4.39 | -8.98 | -211.61 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.